These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36326853)

  • 1. Calciprotein Particle Synthesis Strategy Determines In Vitro Calcification Potential.
    Zeper LW; Smith ER; Ter Braake AD; Tinnemans PT; de Baaij JHF; Hoenderop JGJ
    Calcif Tissue Int; 2023 Jan; 112(1):103-117. PubMed ID: 36326853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of Serum Calciprotein Particle Size and Transformation Time With Arterial Calcification, Arterial Stiffness, and Mortality in Incident Hemodialysis Patients.
    Chen W; Fitzpatrick J; Monroy-Trujillo JM; Sozio SM; Jaar BG; Estrella MM; Serrano J; Anokhina V; Miller BL; Melamed ML; Bushinsky DA; Parekh RS
    Am J Kidney Dis; 2021 Mar; 77(3):346-354. PubMed ID: 32800846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calciprotein particle inhibition explains magnesium-mediated protection against vascular calcification.
    Ter Braake AD; Eelderink C; Zeper LW; Pasch A; Bakker SJL; de Borst MH; Hoenderop JGJ; de Baaij JHF
    Nephrol Dial Transplant; 2020 May; 35(5):765-773. PubMed ID: 31605492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium phosphate microcrystallopathy as a paradigm of chronic kidney disease progression.
    Kuro-O M
    Curr Opin Nephrol Hypertens; 2023 Jul; 32(4):344-351. PubMed ID: 37074676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Secondary Calciprotein Particles in the Mineralisation Paradox of Chronic Kidney Disease.
    Cai MMX; Smith ER; Tan SJ; Hewitson TD; Holt SG
    Calcif Tissue Int; 2017 Dec; 101(6):570-580. PubMed ID: 28861648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of Calciprotein Particles (CPPs) in Serum/Plasma Samples Using a Fluorescent Bisphosphonate.
    Miura Y; Kurosu H; Kuro-O M
    Methods Mol Biol; 2023; 2664():333-341. PubMed ID: 37423998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver and spleen predominantly mediate calciprotein particle clearance in a rat model of chronic kidney disease.
    Zeper LW; Bos C; Leermakers PA; Franssen GM; Raavé R; Hoenderop JGJ; de Baaij JHF
    Am J Physiol Renal Physiol; 2024 Apr; 326(4):F622-F634. PubMed ID: 38420675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular Clearance and Biological Activity of Calciprotein Particles Depend on Their Maturation State and Crystallinity.
    Köppert S; Büscher A; Babler A; Ghallab A; Buhl EM; Latz E; Hengstler JG; Smith ER; Jahnen-Dechent W
    Front Immunol; 2018; 9():1991. PubMed ID: 30233585
    [No Abstract]   [Full Text] [Related]  

  • 9. Novel assessments of systemic calcification propensity.
    Pasch A
    Curr Opin Nephrol Hypertens; 2016 Jul; 25(4):278-84. PubMed ID: 27228365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcification of vascular smooth muscle cells is induced by secondary calciprotein particles and enhanced by tumor necrosis factor-α.
    Aghagolzadeh P; Bachtler M; Bijarnia R; Jackson C; Smith ER; Odermatt A; Radpour R; Pasch A
    Atherosclerosis; 2016 Aug; 251():404-414. PubMed ID: 27289275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic Kidney Disease Circulating Calciprotein Particles and Extracellular Vesicles Promote Vascular Calcification: A Role for GRP (Gla-Rich Protein).
    Viegas CSB; Santos L; Macedo AL; Matos AA; Silva AP; Neves PL; Staes A; Gevaert K; Morais R; Vermeer C; Schurgers L; Simes DC
    Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):575-587. PubMed ID: 29301790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and quantification of plasma calciprotein particles with distinct physical properties in patients with chronic kidney disease.
    Miura Y; Iwazu Y; Shiizaki K; Akimoto T; Kotani K; Kurabayashi M; Kurosu H; Kuro-O M
    Sci Rep; 2018 Jan; 8(1):1256. PubMed ID: 29352150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnesium and calciprotein particles in vascular calcification: the good cop and the bad cop.
    Zeper LW; de Baaij JHF
    Curr Opin Nephrol Hypertens; 2019 Jul; 28(4):368-374. PubMed ID: 31045659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects for inflammatory responses by CPP with different colloidal properties in hemodialysis patients.
    Mukai H; Miura Y; Kotani K; Kotoda A; Kurosu H; Yamada T; Kuro-O M; Iwazu Y
    Sci Rep; 2022 Dec; 12(1):21856. PubMed ID: 36528732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of lanthanum carbonate on calciprotein particles in hemodialysis patients.
    Nakamura K; Nagata Y; Hiroyoshi T; Isoyama N; Fujikawa K; Miura Y; Matsuyama H; Kuro-O M
    Clin Exp Nephrol; 2020 Apr; 24(4):323-329. PubMed ID: 31875935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with advanced chronic kidney disease and vascular calcification have a large hydrodynamic radius of secondary calciprotein particles.
    Chen W; Anokhina V; Dieudonne G; Abramowitz MK; Kashyap R; Yan C; Wu TT; de Mesy Bentley KL; Miller BL; Bushinsky DA
    Nephrol Dial Transplant; 2019 Jun; 34(6):992-1000. PubMed ID: 29788425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical transformation of calciprotein particles in uraemia.
    Smith ER; Hewitson TD; Hanssen E; Holt SG
    Bone; 2018 May; 110():355-367. PubMed ID: 29499417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of Vascular Calcification in Kidney Disease.
    Disthabanchong S; Srisuwarn P
    Adv Chronic Kidney Dis; 2019 Nov; 26(6):417-426. PubMed ID: 31831120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylated fetuin-A-containing calciprotein particles are associated with aortic stiffness and a procalcific milieu in patients with pre-dialysis CKD.
    Smith ER; Ford ML; Tomlinson LA; Rajkumar C; McMahon LP; Holt SG
    Nephrol Dial Transplant; 2012 May; 27(5):1957-66. PubMed ID: 22105144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of calciprotein particle formation by AUC of the absorbance change: effect of FYB-931, a novel bisphosphonate compound.
    Ishida K; Ashizawa N; Morikane S; Kurita N; Kobashi S; Iwanaga T
    J Pharm Pharmacol; 2021 Jun; 73(7):947-955. PubMed ID: 33882129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.